Methods for the treatment of alpha-1 antitrypsin deficiency (AATD)
US-12582668-B2 · Mar 24, 2026 · US
Arrowhead Pharmaceuticals Inc holds 257 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 257 |
| Recent patents | 70 |
| First publication | Jun 28, 2016 |
| Latest publication | Mar 24, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12582668-B2 · Mar 24, 2026 · US
US-12582718-B2 · Mar 24, 2026 · US
US-2026078375-A1 · Mar 19, 2026 · US
US-2026069625-A1 · Mar 12, 2026 · US
US-2026071223-A1 · Mar 12, 2026 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12582668-B2 · Mar 24, 2026 · US
US-12582718-B2 · Mar 24, 2026 · US
US-2026078375-A1 · Mar 19, 2026 · US
US-2026069625-A1 · Mar 12, 2026 · US
US-2026071223-A1 · Mar 12, 2026 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 250 |
| Chemistry & Metallurgy | 250 |
| Cross-Sectional Technologies | 24 |
| Physics | 7 |
| Operations & Transport | 1 |
| Mechanical Engineering | 1 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.